Apr 18, 2025

Featuring an interview with Ms Amy Goodrich, including the following topics:

• Presentation and management of follicular lymphoma (FL) (0:00)
• Case: A woman in her late 70s with heavily pretreated disease experiences complete response to mosunetuzumab (24:41)
• Case: A man in his early 60s with extensive diffuse...

Apr 16, 2025

Featuring an interview with Dr Raajit K Rampal, including the following topics:

• Clinical decision-making in the initiation and stopping of systemic therapy for myelofibrosis (MF) (0:00)
• Novel research strategies involving CDK4/6 inhibitors for MF (8:03)
• Implications of the JUMP study for clinical...

Apr 16, 2025

Featuring a slide presentation and related discussion from Dr Raajit K Rampal, including the following topics:

• Overview of the current JAK inhibitor landscape (0:00)
• Factors predicting clinical benefit in patients with myelofibrosis (MF) receiving ruxolitinib (3:02)
• Clinical data supporting the use of fedratinib after...

Apr 12, 2025

Featuring perspectives from Dr Nicole Lamanna and Dr Kerry Rogers, including the following topics:

• Introduction (0:00)
• Current Role of Covalent Bruton Tyrosine Kinase and Bcl-2 Inhibitors in Managing Chronic Lymphocytic Leukemia — Dr Lamanna (10:55)
• Novel Agents and Combination Strategies — Dr Rogers (31:21)

CME...

Apr 5, 2025

Featuring an interview with Dr Catherine C Coombs, including the following topics:

• Case: A woman in her early 80s with dementia and newly diagnosed IGHV-mutated del(13q) chronic lymphocytic leukemia (CLL) receives initial treatment with zanubrutinib (0:00)
• Current and investigational initial therapy approaches for...